PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
176.45 - 178.59
86.62 - 184.48
124.91M / 173.95M (Avg.)
50.81 | 3.50
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
75.63%
Some net income increase while MRVL is negative at -26.06%. John Neff would see a short-term edge over the struggling competitor.
1.70%
D&A growth well above MRVL's 3.10%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
184.35%
Some yoy growth while MRVL is negative at -8547833.33%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
2.52%
SBC growth while MRVL is negative at -8.59%. John Neff would see competitor possibly controlling share issuance more tightly.
-327.22%
Both reduce yoy usage, with MRVL at -97.11%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
100.62%
AR growth while MRVL is negative at -39.86%. John Neff would note competitor possibly improving working capital while we allow AR to rise.
6.94%
Inventory shrinking or stable vs. MRVL's 175.80%, indicating lean supply management. David Dodd would confirm no demand shortfall.
-151.50%
Both negative yoy AP, with MRVL at -969.50%. Martin Whitman would find an overall trend toward paying down supplier credit in the niche.
-838.58%
Negative yoy usage while MRVL is 223.69%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-100.06%
Negative yoy while MRVL is 11242.12%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-9.66%
Both yoy CFO lines are negative, with MRVL at -27.81%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
27.86%
Some CapEx rise while MRVL is negative at -54.83%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-11.12%
Both yoy lines negative, with MRVL at -147.10%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
-16.47%
We reduce yoy sales while MRVL is 35.32%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
172.82%
We have some outflow growth while MRVL is negative at -2787.61%. John Neff sees competitor possibly pulling back more aggressively from minor expansions or intangible invests.
-115.81%
Both yoy lines negative, with MRVL at -280.36%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-3.02%
We cut debt repayment yoy while MRVL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.